Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease-Reference-Cited by-同舟云学术

Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease

Published:2016-05-16 Issue:11 Volume:76 Page:1024-1033
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Larbi Ahmed¹,Dallaudière Benjamin¹,Pasoglou Vasiliki¹,Padhani Anwar²,Michoux Nicolas¹,Vande Berg Bruno C.¹,Tombal Bertrand³,Lecouvet Frédéric E.¹

Affiliation:

1. Department of Radiology; Institut de Recherche Expérimentale et Clinique (IREC); Cliniques universitaires Saint Luc; Université catholique de Louvain; Brussels Belgium

2. Paul Strickland Scanner Centre; Mount Vernon Hospital; Northwood Middlesex United Kingdom

3. Urology Unit; Institut de Recherche Expérimentale et Clinique (IREC); Cliniques universitaires Saint Luc; Université catholique de Louvain; Brussels Belgium

Funder

Fonds de Recherche Clinique, IREC (AL)

bourse de recherche 2013 de la Société Française de Radiologie (SFR) (BD)

Fond National de la Recherche Scientifique (FNRS)−Télévie, Fondation contre le cancer, Fondation Saint Luc (VP, FL)

Publisher

Wiley

Subject

Urology,Oncology

Reference57 articles.

1. The role of palliative surgery in castration-resistant prostate cancer;Piper;Curr Opin Support Palliat Care,2014

2. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases-Results of a feasibility and case-control study;Heidenreich;J Urol,2015

3. Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review);Faiena;Int J Oncol,2014